GlassScriptPhysician profile
Nehal P Modh
NPI 1619081890
$16,690.49
in general payments reported to CMS, 2019-2025
40 companies · $1,296 in 2025
The $1,296 reported for 2025 was more than what 78% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,867 · 2020: $2,483 · 2021: $4,063 · 2022: $3,306 · 2023: $2,130 · 2024: $1,547 · 2025: $1,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,972.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,761.93 | 2021-2025 | |
| Abbott Laboratories | $2,505.81 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,861.35 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $898.25 | 2019-2025 | Belbuca, Xtampza |
| Pfizer INC. | $841.95 | 2019-2025 | |
| Allergan, INC. | $632.93 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $598.09 | 2019-2022 | |
| Amgen INC. | $580.06 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $520.22 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $459.24 | 2022 | |
| Biodelivery Sciences International, INC. | $436.06 | 2019-2021 | |
| Lilly USA, LLC | $337.88 | 2019-2023 | Reyvow, Emgality |
| Scilex Pharmaceuticals INC. | $328.39 | 2019-2023 | Ztlido |
| Endo Pharmaceuticals INC. | $202.03 | 2019-2021 | |
| Horizon Therapeutics Plc | $183.36 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nehal Modh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.